Skip to main content
Clinical Trials/NCT01216592
NCT01216592
Completed
Not Applicable

Correlations Between Airway Inflammation, Symptoms and Lung Functions in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)

Università degli Studi di Ferrara1 site in 1 country40 target enrollmentJanuary 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Università degli Studi di Ferrara
Enrollment
40
Locations
1
Primary Endpoint
Correlation between changes in airway inflammation and symptom score
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease with high prevalence worldwide and with relevant impact on patient-related quality of life, morbidity and mortality. There is evidence that airway inflammation correlates with the severity of the disease and that airway inflammation is further enhanced during exacerbation. However, it is unknown whether daily fluctuation of symptoms or changes in lung function is paralleled by changes in airway inflammation.

Detailed Description

Patients will undergo a visit every 7 days during one month (5 visits in total). At each visit airway inflammation (exhaled NO, sputum inflammatory cell count) and lung function will be performed. At home patients will be asked to fill a daily diary for symptom assessment.

Registry
clinicaltrials.gov
Start Date
January 2009
End Date
July 2011
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Università degli Studi di Ferrara
Responsible Party
Principal Investigator
Principal Investigator

Alberto Papi

Professor

Università degli Studi di Ferrara

Eligibility Criteria

Inclusion Criteria

  • Post-bronchodilator FEV1/FVC ratio \< 70%
  • Post-bronchodilator FEV1 \< 80%
  • Smokers or ex-smoker with pack/years \> 15

Exclusion Criteria

  • Concomitant lung diseases (e.g. lung cancer)
  • Acute infections of the respiratory tree in the previous 2 months including COPD exacerbation.

Outcomes

Primary Outcomes

Correlation between changes in airway inflammation and symptom score

Time Frame: 1 month,

Correlation between changes in airway inflammation and symptom score will be evaluated

Secondary Outcomes

  • Correlations between airway inflammation and symptom scores(1 month)
  • Correlations between airway inflammation and lung function(1 month)
  • Correlation between changes in airway inflammation and lung function(1 month)

Study Sites (1)

Loading locations...

Similar Trials